These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2787093)

  • 21. Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients.
    Al-Aloul M; Crawley J; Winstanley C; Hart CA; Ledson MJ; Walshaw MJ
    Thorax; 2004 Apr; 59(4):334-6. PubMed ID: 15047956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide.
    Fick RB; Olchowski J; Squier SU; Merrill WW; Reynolds HY
    Am Rev Respir Dis; 1986 Mar; 133(3):418-22. PubMed ID: 3082264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis and the possible role of contamination by dental equipment.
    Jensen ET; Giwercman B; Ojeniyi B; Bangsborg JM; Hansen A; Koch C; Fiehn NE; Høiby N
    J Hosp Infect; 1997 Jun; 36(2):117-22. PubMed ID: 9211158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success?--A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection.
    Johansen HK; Nørregaard L; Gøtzsche PC; Pressler T; Koch C; Høiby N
    Pediatr Pulmonol; 2004 May; 37(5):427-32. PubMed ID: 15095326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective surveillance for Pseudomonas aeruginosa cross-infection at a cystic fibrosis center.
    Jones AM; Dodd ME; Govan JR; Doherty CJ; Smith CM; Isalska BJ; Webb AK
    Am J Respir Crit Care Med; 2005 Feb; 171(3):257-60. PubMed ID: 15542795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis.
    Viel M; Hubert D; Burgel PR; Génin E; Honoré I; Martinez B; Gaitch N; Chapron J; Kanaan R; Dusser D; Girodon E; Bienvenu T
    Clin Respir J; 2016 Nov; 10(6):777-783. PubMed ID: 25763772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis.
    Kidd TJ; Soares Magalhães RJ; Paynter S; Bell SC;
    Lancet Respir Med; 2015 Aug; 3(8):640-50. PubMed ID: 26208994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
    Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
    Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eradication of early Pseudomonas aeruginosa infection.
    Høiby N; Frederiksen B; Pressler T
    J Cyst Fibros; 2005 Aug; 4 Suppl 2():49-54. PubMed ID: 16023416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secretory IgA response against Pseudomonas aeruginosa in the upper airways and the link with chronic lung infection in cystic fibrosis.
    Mauch RM; Rossi CL; Aiello TB; Ribeiro JD; Ribeiro AF; Høiby N; Levy CE
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28645157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center.
    Lee TW; Brownlee KG; Denton M; Littlewood JM; Conway SP
    Pediatr Pulmonol; 2004 Feb; 37(2):104-10. PubMed ID: 14730654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudomonas aeruginosa transmission is infrequent in New Zealand cystic fibrosis clinics.
    Schmid J; Ling LJ; Leung JL; Zhang N; Kolbe J; Wesley AW; Mills GD; Brown PJ; Jones DT; Laing RT; Pattemore PK; Taylor DR; Grimwood K
    Eur Respir J; 2008 Dec; 32(6):1583-90. PubMed ID: 18715877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients.
    Jelsbak L; Johansen HK; Frost AL; Thøgersen R; Thomsen LE; Ciofu O; Yang L; Haagensen JA; Høiby N; Molin S
    Infect Immun; 2007 May; 75(5):2214-24. PubMed ID: 17261614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
    Bradbury R; Champion A; Reid DW
    Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients.
    Høiby N; Pedersen SS
    Antibiot Chemother (1971); 1989; 42():124-9. PubMed ID: 2596835
    [No Abstract]   [Full Text] [Related]  

  • 37. The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis.
    Tablan OC; Martone WJ; Jarvis WR
    Eur J Epidemiol; 1987 Dec; 3(4):336-42. PubMed ID: 3319668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Pier GB
    Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.
    Holby N; Olling S
    Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):107-14. PubMed ID: 404841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Prevalence of Pseudomonas Aeruginosa Infection Over a Ten-Year Period in Children with Cystic Fibrosis.
    Al Shidhani K; O’Reilly R; Javadpour S; O’Sullivan N; McNally P; Cox DW
    Ir Med J; 2019 Jun; 112(6):946. PubMed ID: 31535835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.